Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IBB vs HTEC overlap: 20% of top holdings shared

Bottom line

How much do IBB and HTEC overlap?

20% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 22.8% of IBB's assets and 14.2% of HTEC's. They are substantially different portfolios, so owning both adds real diversification.

IBB holds far more positions (254 vs 63), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

IBBHTEC
Weight overlap (top 25)20%
Shared holdings7
Weight in shared holdings22.8%14.2%
Total positions25463
Expense ratio0.44%0.68%
Holdings as ofSep 30, 2025Jul 31, 2026

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Holdings IBB and HTEC have in common

Holding% of IBB% of HTECOverlap
Vertex Pharmaceuticals, Inc.7.66%1.91%1.91%
Regeneron Pharmaceuticals, Inc.5.70%1.97%1.97%
IQVIA Holdings, Inc.3.18%2.10%2.10%
Natera, Inc.2.11%2.23%2.11%
Incyte Corp.1.62%1.80%1.62%
Illumina, Inc.1.41%2.09%1.41%
Medpace Holdings, Inc.1.16%2.12%1.16%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IBB

  1. BlackRock Funds III — 13.18%
  2. Gilead Sciences, Inc. — 7.52%
  3. Amgen, Inc. — 7.50%
  4. Alnylam Pharmaceuticals, Inc. — 5.68%
  5. Argenx SE — 3.15%
  6. Insmed, Inc. — 2.95%
  7. Mettler-Toledo International, Inc. — 2.49%
  8. BeOne Medicines Ltd. — 2.11%
  9. Biogen, Inc. — 2.03%
  10. United Therapeutics Corp. — 1.82%
  11. Waters Corp. — 1.77%
  12. Genmab A/S — 1.38%
  13. Neurocrine Biosciences, Inc. — 1.34%
  14. Exelixis, Inc. — 1.07%
  15. Ionis Pharmaceuticals, Inc. — 1.03%

Only in HTEC

  1. Caredx, Inc. — 2.68%
  2. Guardant Health, Inc. — 2.31%
  3. Twist Bioscience Corp — 2.23%
  4. Thermo Fisher Scientific Incorporated — 2.18%
  5. Adaptive Biotechnologies Corporation — 2.11%
  6. Arrowhead Pharmaceuticals, Inc. — 2.08%
  7. Glaukos Corporation — 1.92%
  8. Stryker Corporation — 1.91%
  9. Livanova Plc — 1.87%
  10. Siemens Healthineers AG — 1.85%
  11. Lonza Group AG — 1.85%
  12. Abbott Laboratories — 1.79%
  13. AxoGen, Inc. — 1.77%
  14. Boston Scientific Corporation — 1.73%
  15. Grail Inc — 1.72%

Asset mix

Asset typeIBBHTEC
Stocks99.8%99.8%
Cash & short-term funds13.4%0.2%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Country mix

CountryIBBHTEC
US98.6%82.9%
CH2.7%5.0%
NL4.3%1.6%
HK—3.7%
DK2.2%—
DE0.7%1.9%
FR—1.6%
IT—1.3%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Check another pair

FAQ

How much do IBB and HTEC overlap?
About 20% by weight. 7 securities appear in both funds' top 25 holdings; they make up 22.8% of IBB's assets and 14.2% of HTEC's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do IBB and HTEC have in common?
The largest shared holdings are Natera, Inc., IQVIA Holdings, Inc., Regeneron Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., Incyte Corp..
Should I own both IBB and HTEC?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, IBB or HTEC?
IBB is broader, with 254 positions versus 63 for HTEC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.